BETHLEHEM, Pa. – OraSure Applied sciences is lastly exhibiting off the large investments it is made in South Bethlehem because the begin of the pandemic.
“When you look from a capital standpoint and also you embody cash we have been awarded by the federal authorities, OraSure is investing about $150 million because the begin of 2020,” mentioned Interim CFO Scott Gleason.
And that meant reworking its second-floor workplace house into manufacturing house to satisfy demand for its speedy COVID antigen assessments – the InteliSwab.
“We’re making an attempt to broaden to satisfy the wants of the nation,” Gleason mentioned.
“As I used to be telling them inside, I’ve used the InteliSwab on quite a lot of events now myself and it is only a nice feeling of pleasure,” mentioned Congresswoman Susan Wild, who was available for the tour.
“They’re persevering with to rent, and so they rent folks in any respect ranges. I imply folks popping out of highschool which have any technical bent or curiosity within the sciences, they do not should be educated,” Wild mentioned.
“They will come right here and study.”
The corporate did report an working loss final yr. Gleason says that was associated to upscaling manufacturing for the InteliSwab and says it is on monitor for record-setting income in 2022.
“There’s a variety of inefficiencies related to that. You already know as we transition this yr, we’re hoping to realize worthwhile development,” Gleason mentioned.
The corporate is working in partnership with the federal government on one other enlargement sooner or later.
“That facility, we’re at present on the lookout for a website,” Gleason mentioned.
I did ask the corporate in the event that they have been planning on placing that upcoming enlargement within the Lehigh Valley. The corporate mentioned it is a chance however, once more, no location has been picked but.